Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients
Bariatric Surgery Candidate, Nausea, Postoperative
About this trial
This is an interventional prevention trial for Bariatric Surgery Candidate
Eligibility Criteria
Inclusion Criteria:
- Bariatric surgery candidate on 7-Lime at Lancaster General Hospital
- Scheduled for laparoscopic sleeve gastrectomy and laparoscopic Roux-En-Y (RNY) procedures
- Between ages of 18 and 70
- Surgical patient of either Dr. James Ku and Dr. Joseph McPhee
Exclusion Criteria:
- History of excessive sensitivity to peppermint oil, allergic response to peppermint oil and who state preference against aromatherapy
- Not alert and oriented or unable to follow directions will be excluded
- Severe reactive airway disease such as asthma or chronic obstructive pulmonary disease (COPD)
- Possible exclusion for severe hypertension or atrial fibrillation
Sites / Locations
- Lancaster General Hospital
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
Patients in the control group will not receive peppermint oil aromatherapy as a primary intervention for postoperative nausea and vomiting. Primary therapy for postoperative nausea and vomiting would entail standard antiemetic drug therapies. Patient monitoring and documentation would include the following: Patients in the control group will be assessed every 4 hours and as needed for nausea. All aspects of care from physician, nursing and all disciplines will be consistent with current practices in care of postoperative bariatric surgical patients.
Patients in the intervention group will receive peppermint oil aromatherapy as primary treatment for postoperative nausea. Pharmacological therapy with anti-nausea drug therapies will be available as needed. All other aspects of medical, surgical and nursing care will be standard practice for pre and post-operative care related to the bariatric surgical patient. Patients in the intervention group will be assessed every 4 hours and as needed for nausea. Post-intervention, the patient will be re-assessed for level of nausea after one hour. In the event the patient refuses peppermint oil aromatherapy and requests anti-emetic drug therapies, they are able to do so.